Ophthalmology

Top Story

No difference found in stroke type with or without anti-VEGFs

August 21, 2017

BOSTON — No differences in type or anatomic distribution of strokes were seen in patients who received intravitreal anti-VEGF injections compared with patients with similar disease processes who did not receive anti-VEGF injections, according to a study presented at the American Society of Retina Specialists meeting here.

Sophie J. Bakri, MD, presented a retrospective review of patient records in the Rochester Epidemiology Project, a validated health care database of patients in Olmsted County, Minnesota. The study looked at location and types of strokes, both hemorrhagic and ischemic, in patients receiving anti-VEGFs to help address the “conflicting data regarding whether there is an association between intravitreal anti-VEGF and stroke.”

Trump signs FDA Reauthorization Act of 2017 into law

August 21, 2017
President Donald J. Trump recently signed the FDA Reauthorization Act of 2017 into law. The

SightLife names new CEO

August 21, 2017
SightLife has named Claire Bonilla as its new CEO. Bonilla, who most recently served as the organization’s chief global officer, will also join its board.
Meeting News

Reduced diabetic retinopathy severity can enhance functional vision

August 21, 2017
BOSTON — Ranibizumab treatment for diabetic retinopathy, with or without diabetic macular edema, may regress the severity of the retinopathy to a milder stage…

PUBLICATION EXCLUSIVE: Advances in glaucoma management blur the barriers between subspecialties

August 21, 2017
Glaucoma management has undergone significant advancements in recent years. New minimally invasive surgical options have become available, filling in the gap between…
More Headlines »
Original Article

Enhancement After Myopic Small Incision Lenticule Extraction (SMILE) Using Surface Ablation

Journal of Refractive Surgery, August 2017, Volume 33 Issue 8
To report the feasibility and outcomes of surface ablation after small incision lenticule extraction (SMILE). In this…
More »
CME

Inflamed and Untamed: Managing the Progression of Diabetic Eye Disease

This activity is supported by an educational grant from Allergan, Inc.

Diabetic retinopathy (DR) is a major cause of blindness, with an estimated 4.2 million people over the age of 40…
More »
Resource Centers
American Society of Retina Specialists Meeting

American Society of Retina Specialists Meeting

Video
Meeting News

VIDEO: Teleophthalmology, AI set to improve health care delivery, outcomes

August 18, 2017
More »
Advertisement
Advertisement